Cargando…

Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices

The bioactivity of the IGF system is not a function of isolated hormone concentrations in a given biological matrix. Instead, the biological activities of IGFs are regulated by IGFBPs, IGFBP proteases, and inhibitors of IGFBP proteases. Therefore, assays based on IGF-related bioactivity may describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Walz, Michael, Höflich, Christine, Walz, Christina, Ohde, Daniela, Brenmoehl, Julia, Sawitzky, Mandy, Vernunft, Andreas, Zettl, Uwe K., Holtze, Susanne, Hildebrandt, Thomas B., Wolf, Eckhard, Hoeflich, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995968/
https://www.ncbi.nlm.nih.gov/pubmed/33668197
http://dx.doi.org/10.3390/cells10030482
_version_ 1783670018344484864
author Walz, Michael
Höflich, Christine
Walz, Christina
Ohde, Daniela
Brenmoehl, Julia
Sawitzky, Mandy
Vernunft, Andreas
Zettl, Uwe K.
Holtze, Susanne
Hildebrandt, Thomas B.
Wolf, Eckhard
Hoeflich, Andreas
author_facet Walz, Michael
Höflich, Christine
Walz, Christina
Ohde, Daniela
Brenmoehl, Julia
Sawitzky, Mandy
Vernunft, Andreas
Zettl, Uwe K.
Holtze, Susanne
Hildebrandt, Thomas B.
Wolf, Eckhard
Hoeflich, Andreas
author_sort Walz, Michael
collection PubMed
description The bioactivity of the IGF system is not a function of isolated hormone concentrations in a given biological matrix. Instead, the biological activities of IGFs are regulated by IGFBPs, IGFBP proteases, and inhibitors of IGFBP proteases. Therefore, assays based on IGF-related bioactivity may describe functions of the complete IGF system in a given biological matrix. Of particular interest are the IGF system effects on the AKT/mTOR pathway, as a dominant system for controlling growth, metabolism, and aging. In order to improve the sensitivity of IGF-dependent bioactivity, we made use of the known short-term and enhancing effects of IGFBP2 on the intracellular PI3K pathway. As a specific readout of this pathway, and further as a marker of the mTOR pathway, we assessed the phosphorylation of AKT-Ser473. Preincubation using IGFBP2 enhanced IGF1-dependent AKT-Ser473 phosphorylation in our experimental system. The assay’s specificity was demonstrated by inhibition of IGF1 receptors outside or inside the cell, using antiserum or small molecule inhibitors, which reduced AKT phosphorylation in response to exogenous IGF1 (p < 0.05). The maximal response of AKT phosphorylation was recorded 15 to 60 min after the addition of IGF1 to cell monolayers (p < 0.001). In our cellular system, insulin induced AKT phosphorylation only at supra-physiological concentrations (µM). Using this novel assay, we identified the differential biological activity of the IGF system in AKT-Ser473 phosphorylation in serum (mouse, naked mole rat, and human), in cerebrospinal fluid (human), and in colostrum or mature milk samples (dairy cow). We have developed a sensitive and robust bioassay to assess the IGF-related activation of the AKT/mTOR pathway. The assay works efficiently and does not require expensive cell culture systems. By using capillary immuno-electrophoresis, the readout of IGF-related bioactivity is substantially accelerated, requiring a minimum of hands-on time. Importantly, the assay system is useful for studying IGF-related activity in the AKT/mTOR pathway in a broad range of biological matrices.
format Online
Article
Text
id pubmed-7995968
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79959682021-03-27 Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices Walz, Michael Höflich, Christine Walz, Christina Ohde, Daniela Brenmoehl, Julia Sawitzky, Mandy Vernunft, Andreas Zettl, Uwe K. Holtze, Susanne Hildebrandt, Thomas B. Wolf, Eckhard Hoeflich, Andreas Cells Article The bioactivity of the IGF system is not a function of isolated hormone concentrations in a given biological matrix. Instead, the biological activities of IGFs are regulated by IGFBPs, IGFBP proteases, and inhibitors of IGFBP proteases. Therefore, assays based on IGF-related bioactivity may describe functions of the complete IGF system in a given biological matrix. Of particular interest are the IGF system effects on the AKT/mTOR pathway, as a dominant system for controlling growth, metabolism, and aging. In order to improve the sensitivity of IGF-dependent bioactivity, we made use of the known short-term and enhancing effects of IGFBP2 on the intracellular PI3K pathway. As a specific readout of this pathway, and further as a marker of the mTOR pathway, we assessed the phosphorylation of AKT-Ser473. Preincubation using IGFBP2 enhanced IGF1-dependent AKT-Ser473 phosphorylation in our experimental system. The assay’s specificity was demonstrated by inhibition of IGF1 receptors outside or inside the cell, using antiserum or small molecule inhibitors, which reduced AKT phosphorylation in response to exogenous IGF1 (p < 0.05). The maximal response of AKT phosphorylation was recorded 15 to 60 min after the addition of IGF1 to cell monolayers (p < 0.001). In our cellular system, insulin induced AKT phosphorylation only at supra-physiological concentrations (µM). Using this novel assay, we identified the differential biological activity of the IGF system in AKT-Ser473 phosphorylation in serum (mouse, naked mole rat, and human), in cerebrospinal fluid (human), and in colostrum or mature milk samples (dairy cow). We have developed a sensitive and robust bioassay to assess the IGF-related activation of the AKT/mTOR pathway. The assay works efficiently and does not require expensive cell culture systems. By using capillary immuno-electrophoresis, the readout of IGF-related bioactivity is substantially accelerated, requiring a minimum of hands-on time. Importantly, the assay system is useful for studying IGF-related activity in the AKT/mTOR pathway in a broad range of biological matrices. MDPI 2021-02-24 /pmc/articles/PMC7995968/ /pubmed/33668197 http://dx.doi.org/10.3390/cells10030482 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Walz, Michael
Höflich, Christine
Walz, Christina
Ohde, Daniela
Brenmoehl, Julia
Sawitzky, Mandy
Vernunft, Andreas
Zettl, Uwe K.
Holtze, Susanne
Hildebrandt, Thomas B.
Wolf, Eckhard
Hoeflich, Andreas
Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices
title Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices
title_full Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices
title_fullStr Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices
title_full_unstemmed Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices
title_short Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices
title_sort development of a sensitive bioassay for the analysis of igf-related activation of akt/mtor signaling in biological matrices
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995968/
https://www.ncbi.nlm.nih.gov/pubmed/33668197
http://dx.doi.org/10.3390/cells10030482
work_keys_str_mv AT walzmichael developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT hoflichchristine developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT walzchristina developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT ohdedaniela developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT brenmoehljulia developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT sawitzkymandy developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT vernunftandreas developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT zettluwek developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT holtzesusanne developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT hildebrandtthomasb developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT wolfeckhard developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices
AT hoeflichandreas developmentofasensitivebioassayfortheanalysisofigfrelatedactivationofaktmtorsignalinginbiologicalmatrices